Jeffrey Moore
InvestorPresident at MC Healthcare Ventures
Boston, Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
Find your path to Jeffrey
527 people in our graph share verified history with Jeffrey β schools, employers, funds. One of them is your warm intro.
Dominic JacquessonunlockedJeffrey: together at University of Oxford (1990β1992)
Γ2Jeffrey: together at F-star Therapeutics, Inc.
Γ4Jeffrey: together at MIT Sloan School of Management
Γ3Jeffrey: together at University of Oxford
About
Dr. Jeff Moore joined MPH in 2008 with experience as a scientist, businessman, and investor, specializing in biochemistry, infectious disease, and immunology. He works closely with the firm's early-stage portfolio companies including F-star, Forge, and QurAlis.
ContactΒ· self-published, not guessed
Experience
- MP Healthcare Venture ManagementPresident & Board Member2008 β 2026Boston, MA
- TRIMTECH Therapeutics LimitedBoard Member2026Cambridge
- PharmEnableBoard Member2022 β 2026Cambridge
- Outrun TherapeuticsBoard Member2021 β 2026
- Blacksmith MedicinesBoard Observer2021 β 2026
- CapsigenBoard Member2020 β 2026
- Ribometrix Inc.Board Observer2020 β 2026
- Sonde Health, Inc.Board Observer2020 β 2026
- Forge Therapeutics, Inc.Board Observer2017 β 2026
- Diamond Edge VenturesBoard Member2018 β 2025Menlo Park, CA
- SOLA BiosciencesBoard Member2021 β 2024Natick, MA
- Korro Bio, Inc.Board Observer2020 β 2023
- F-star Therapeutics, Inc.Board Observer2009 β 2020
- QurAlisBoard Member2018 β 2020Cambridge, MA
- Thrasos Innovation Inc.Board Observer2012 β 2018
- Rigontec GmbHBoard Observer2015 β 2017
- miRagen Therapeutics, Inc.Board Observer2015 β 2017
- GenoceaBoard Observer2010 β 2014
- Intradigm CorporationBoard Observer2008 β 2010
- Covagen AGBoard Observer2009
Skills & more
Target IdentificationSandEarly Stage InvestmentFrenchInvestment DecisionsEnglishReporting & AnalysisMilestonesGuitar PlayingMarketing ScienceProposal EvaluationDue Diligence
+8 more
Portfolio ManagementNASDAQStaff DevelopmentMedical DiagnosticsThird-Party Logistics (3PL)Investment StrategiesProfessional DevelopmentTravelLanguages French Β· Spanish
From Jeffrey's professional profile.
Investments
Investor
Outrun TherapeuticsPharmEnableQuralisTRIMTECH Therapeutics
Per curated public sources.
Colleagues at MC Healthcare Ventures
Network1
Investors connected to Jeffrey in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Jeffrey Moore?
- Dr. Jeff Moore joined MPH in 2008 with experience as a scientist, businessman, and investor, specializing in biochemistry, infectious disease, and immunology. He works closely with the firm's early-stage portfolio companies including F-star, Forge, and QurAlis.
- Where does Jeffrey Moore work?
- Jeffrey Moore is President at MC Healthcare Ventures.
- What check size does Jeffrey Moore write?
- Jeffrey Moore typically writes checks of $100K β $5M.
- What companies has Jeffrey Moore invested in?
- Investments tracked here include Outrun Therapeutics, PharmEnable, Quralis, TRIMTECH Therapeutics.
- Where did Jeffrey Moore go to school?
- Jeffrey Moore studied at MIT Sloan School of Management (MBA - Sloan Fellow, Finance & Entrepreneurship); University of Oxford (DPhil, Virology, Molecular Biology, Immunology); Marine Biological Laboratory (Biology of Parasitism Summer Course).
Same school
Also attended MIT Sloan School of Management924
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 918 more
Also attended Marine Biological Laboratory1
Shared employers
Also worked at TRIMTECH Therapeutics Limited6
Damian Crowtherex-AstraZeneca at PICUS CAPITALMichael AnsteyPartner at Cambridge Innovation CapitalHakan GokerManaging Director at M VenturesGeorgia FrostSenior Associate at Dementia DiscoveryGeorgia FrostVice President at Dementia Discovery FundMarie-Claire PeakmanExecutive Director, WWBD / Partner at Pfizer Venture Investments
Also worked at PharmEnable2
Also worked at Sonde Health, Inc.10
Daniel FrankePrincipal at M VenturesJim SchwoebelCEO at QuomeLaura TadvalkarManaging Director, Venture at RA CapitalMichael ChenExecutive Officer at Seaport TherapeuticsHarry LeiderChief Medical Officer at Nsight HealthDavid LiuChief Executive Officer at Sondehealth
+ 4 more













































